期刊文献+

辛伐他汀与洛伐他汀治疗高脂血症疗效比较 被引量:11

Simvastatin vs lovastatin in treating hyperlipidemia
下载PDF
导出
摘要 目的 :观察小剂量辛伐他汀与洛伐他汀治疗高脂血症的疗效和安全性。方法 :12 9例原发性高胆固醇血症随机分为 2组 ,辛伐他汀组 64例 (男性 30例 ,女性 34例 ;年龄 51a±s8a)给予辛伐他汀5mg ,po ,qn× 3mo ;洛伐他汀组 65例 (男性 32例 ,女性 33例 ;年龄 57a± 9a)给予洛伐他汀 10mg ,po ,qn× 3mo。结果 :治疗 3mo后 2组均有TC ,TG ,LDL C ,ApoB10 0 显著下降及HDL C升高作用 ;经t检验 ,治疗前后差别均有非常显著意义(P <0 .0 1) ,2组间比较HDL C ,ApoAI升高差别有显著意义 (P <0 .0 5) ,LDL C ,ApoB10 0 降低差别有非常显著意义 (P <0 .0 1)。 2组均未见明显不良反应。结论 AIM: To determine the safety and efficacy of small dose simvastatin and lovastatin in hyperchlolesterolemia. METHODS: Primary hyperchlolesterolemia 129 patients were divided into 2 groups in random. The simvastatin group with 64 patients (M30,F34,age 51 a±s 8 a) were given 5 mg po,qn×3 mo and the lovastatin group with 65 patients (M32,F33,age 57 a±9 a) were given 10 mg, po, qn×3mo. RESULTS: In these two groups the levels of TC,TG,LDLC,Apo B 100 decreased and HDLC increased (P<0.01) after 3 mo of treatment, but between the two groups HDLC, Apo AI increased and LDLC, Apo B 100 decreased were significant difference (P<0.05 or P<0.01). In the two groups the adverse reaction were mild. CONCLUSION: Small dose simvastatin and lovastatin in treating hyperlipidemia has better effect and safe.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2000年第4期264-266,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 辛伐他汀 洛伐他汀 高脂血症 药物疗法 疗效 simvastatin lovastatin hyperlipidemia
  • 引文网络
  • 相关文献

参考文献3

二级参考文献3

  • 1李健斋,Chinese Medical Journal,1988年,10卷,659页
  • 2王嘉瑾,中华医学检验杂志,1988年,11卷,2页
  • 3杜志民,新药与临床,1997年,16卷,63页

共引文献37

同被引文献57

  • 1王钟林.血脂调整剂的合理应用[J].临床内科杂志,1995,12(1):2-4. 被引量:8
  • 2寇文钅容,陆宗良,孙继良,贾云香,李芬,张利萍.低剂量舒降之治疗中度原发性高胆固醇血症[J].中国新药杂志,1996,5(5):354-357. 被引量:17
  • 3杜志民,曾群英,董吁钢,胡承恒.脂必妥(60例)与辛伐他汀(30例)治疗高脂血症的比较[J].新药与临床,1997,16(1):63-64. 被引量:20
  • 4刘晓惠 胡大一 等.不同剂量辛伐他汀对血脂水平的影响[J].中华心血管病杂志,1998,26(1):113-113.
  • 5维德临床用药年鉴.1998年版.北京:中信出版社,法国OVP-维德出版社,1998:517.
  • 6Pedersen T R, Kjeekshus J, Berg K, et al. Cholesrenrol lowering and the utillization of healthcare resouces:Results of the Scandinavian Simrastatin Survival Study (4S) . Circulation, 1996,93 (10) :1796.
  • 7Deslypere JP , Delanghe J, Vermeulen A, et al. Proteinuria as complication of simvastatin treatment. Lancet,1990,336: 1453.
  • 8Anonymous. Simvastatin and alopecia. Aust Adverse Drug React Bull, 1993, 12: 7.
  • 9Duits N, Bos FM. Depressive symptoms and cholestrol lowering drugs. Lancet, 1993, 341: 114.
  • 10Schaefer EJ. HMG-Co A reductase inhibitors for hypercholesterolemia. N Engl J Med, 1988, 319: 1222.

引证文献11

二级引证文献44

;
使用帮助 返回顶部